Blank Checks · SIC 6770

Aimei Health Technology Co., Ltd.

AFJKU

Watch

Latest revenue

as of 2025-12-31

Latest net income

$1.1M

as of 2025-12-31

Net margin

as of 2025-12-31

8.3
of 10

ActaClear Score

Strong
#93 of 432 in Blank Checks
new
Profitability·25%
8.9
Growth·15%
Value·20%
7.7
Quality·20%
Momentum·20%
8.2

Computed from 5 years of SEC fundamentals + latest market data, ranked within Blank Checks (432 peers). 10 = best in industry, 5 = median, 0 = worst. Refreshed Jun 6, 2026.

8.65
Price / FV

Fair value · DCF

Deeply overvalued
~88% downside at this growth
5.0% / yr
-5%30%
Terminal growthWACC 9.8% · 10y forecast
Current price
$48.85
DCF fair value
$5.65
FCF base (last FY)
$1.06M
Net debt
$-2,929

DCF: 10-year forecast of free cash flow, discounted at the company's WACC, with a Gordon-growth terminal at year 10. FCF is proxied by last fiscal-year net income (proper FCF needs CFO − CapEx by year, which we don't store yet). Drag the slider to test your own growth thesis — the dominant assumption in any DCF is what comes next, not what the math does with it. Beta defaults to 1.0 when not reported.

Community sentiment

Where do you think AFJKU is heading?

1 month
6 months
12 months
5 years
Sign in free to vote and see community sentiment

Price · 5Y

+87.8% / yr 68.1 pts / yr vs S&P 500 380.8% total
Compare:

Live market

delayed ≤15 min
$48.85
0.00%
Market cap
$154.7M
Enterprise value
$156.7M
P/E (trailing)
146.0×
Forward P/E
P/B
Dividend yield
0.0%
52-wk high
$80.00
52-wk low
$0.00
Beta
Shares out
3.2M

5-year trend

What this company does

AI

Aimei Health Technology is a Cayman Islands blank-check SPAC formed in 2023 to acquire a small-cap business in biopharma, medical devices, diagnostics, or healthcare services. It has no operations or revenue; it holds roughly $69.7 million in trust from its December 2023 IPO, earning interest until a deal closes or funds are returned. The company has signed a definitive merger agreement with United Hydrogen Group and extended its deadline to complete a combination to up to 36 months post-IPO.

Generated from AFJKU's filing dated 2026-05-04

Key risks

AI
  • Deadline risk: SPAC must close United Hydrogen deal by December 2026 (36-month extended limit) or liquidate Trust and dissolve.
  • Single-target dependency: Entire thesis hinges on June 2024 United Hydrogen merger closing, pending shareholder votes, F-4 effectiveness, and CSRC approvals.
  • Redemption/dilution risk: Closing requires $5,000,001 net tangible assets post-redemption; heavy redemptions could break the deal or leave minimal float.

Generated from AFJKU's filing dated 2026-05-04

Profitability

Return on equity

-71.8%

96.2%

Return on assets

8.8%

153.2%

Leverage

Debt / equity

-9.20×

98.3%

Debt / assets

112.2%

12.0%

Earnings tracker

QuarterRevenueYoYNet incomeYoYNet margin

Q4 2025

2025-12-31

$98.1K-77.9%

Q3 2025

2025-09-30

$352.0K-52.7%

Q2 2025

2025-06-30

$425.0K-30.2%

Q1 2025

2025-03-31

$184.7K-75.6%

Q4 2024

2024-12-31

$444.1K

Q3 2024

2024-09-30

$743.5K+20650.3%

Q2 2024

2024-06-30

$609.1K

Q1 2024

2024-03-31

$755.5K

Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.

Industry trend

Blank Checks · SIC 6770

Your notes

Keep private notes on AFJKU — thesis, target price, catalysts to watch.

Visible only to you. Never shared. Never used to train AI.

Sign in to write a note

Insider activity

No insider transactions on file for AFJKU in the last 12 months.

Source: SEC Form 4 filings. Backfill runs nightly.

Who owns AFJKU

Institutional value

$25.6K

Total shares held

2.3K

Distinct holders

2

+0 vs prior

As of

2025-09-30

Prior: 2025-06-30

Filers with $100M+ AUM disclose holdings 45 days after quarter end.

Top institutional holders

#ManagerSharesValueQoQ changeAction
1Clear Street Group Inc.2.3K$25.6KNew
2UBS Group AG7$78New

Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.

Top questions investors are asking

AI
  1. 1

    With the United Hydrogen deal pending since June 2024, what specific closing conditions remain unmet and what's your realistic completion date?

  2. 2

    Why pivot from biopharma/medtech mandate to hydrogen via United Hydrogen, and what diligence justifies that strategic departure for shareholders?

  3. 3

    What's the current Trust Account balance after extensions, and what monthly sponsor contributions fund the 24 one-month extensions through December 2026?

Refreshed when AFJKU files a new report · last from 2026-05-04

Investor sentiment
No votes yet
0 this week · 0 total

Sign in to vote. Votes use 7-day half-life decay.

What matters about AFJKU?
Tap any that apply. Aggregates show what other investors flag.

Sign in to tap. 7-day half-life decay.

Latest filing impact
After reading, did this filing make you: